Ricavi e Utile Adaptimmune Therapeutics PLC
Dati in milioni di USD
Bilancio annuale Adaptimmune Therapeutics PLC
| Anno | Ricavi | Utile |
|---|---|---|
| 2021 | 6,15 | -158,09 |
| 2020 | 3,96 | -130,09 |
| 2019 | 1,12 | -137,17 |
| 2018 | 59,51 | -95,51 |
| 2017 | 37,83 | -70,14 |
Trimestrali Adaptimmune Therapeutics PLC
| Trimestre | Ricavi | Utile |
|---|---|---|
| 1Q2020 | 0,76 | -28,17 |
| 2Q2020 | 0,50 | -29,88 |
| 3Q2020 | 1,19 | -35,43 |
| 4Q2020 | 1,50 | -36,61 |
| 1Q2021 | 0,43 | -37,76 |
| 2Q2021 | 3,10 | -39,07 |
| 3Q2021 | 1,20 | -42,40 |
| 4Q2021 | 1,42 | -38,86 |
| 1Q2022 | 3,58 | -50,27 |
| 2Q2022 | 5,54 | -44,52 |
| 3Q2022 | 7,01 | -41,42 |